215 related articles for article (PubMed ID: 27839749)
1. Successful treatment with omalizumab in challenge confirmed exercise-induced anaphylaxis.
Christensen MJ; Bindslev-Jensen C
J Allergy Clin Immunol Pract; 2017; 5(1):204-206. PubMed ID: 27839749
[No Abstract] [Full Text] [Related]
2. Anaphylaxis due to progesterone hypersensitivity successfully treated with omalizumab.
Heffler E; Fichera S; Nicolosi G; Crimi N
J Allergy Clin Immunol Pract; 2017; 5(3):852-854. PubMed ID: 28258855
[No Abstract] [Full Text] [Related]
3. Anaphylaxis to vapors of roasting chicken controlled by omalizumab.
Barnig C; Hilger C; Muti D; Blaumeiser M; Purohit A; Hentges F; de Blay F
J Investig Allergol Clin Immunol; 2012; 22(6):439-40. PubMed ID: 23101190
[No Abstract] [Full Text] [Related]
4. Treatment of moderate to severe pediatric asthma: Omalizumab and potential future use of monoclonal antibodies.
Wright LS; Phipatanakul W
Ann Allergy Asthma Immunol; 2016 Jul; 117(1):17-20. PubMed ID: 27371967
[No Abstract] [Full Text] [Related]
5. Omalizumab for hypersensitive reaction to seminal plasma: A case report.
Burguete-Cabanas MT; Fajardo-Ramirez OR; Yesaki R; Estrada-Maganas R; Salazar-Meza S; Rios-Chavez O; Meester I; Salas-Alanis JC
Allergol Int; 2018 Apr; 67(2):278-279. PubMed ID: 28821383
[No Abstract] [Full Text] [Related]
6. Urticaria, Angioedema, and Anaphylaxis.
Pier J; Bingemann TA
Pediatr Rev; 2020 Jun; 41(6):283-292. PubMed ID: 32482691
[TBL] [Abstract][Full Text] [Related]
7. Use of omalizumab in uncontrolled chronic spontaneous urticaria also improved latex-induced contact urticaria.
Di Leo E; Calogiuri G; Macchia L; Nettis E
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):300-302. PubMed ID: 29802908
[No Abstract] [Full Text] [Related]
8. Treatment of idiopathic anaphylaxis with omalizumab.
Sanchez-Valenzuela MC; Garcia-Saucedo JC; Motoa G; Carrillo-Martin I; Gonzalez-Estrada A
Ann Allergy Asthma Immunol; 2019 Dec; 123(6):612-613. PubMed ID: 31568858
[No Abstract] [Full Text] [Related]
9. Omalizumab in the treatment of antihistamine-resistant chronic urticaria in adults.
Gómez-Vera J; Gutiérrez-Ávila SA; Acosta-Gutiérrez DN; López-Tiro JJ; Bedolla-Barajas M
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):204-6. PubMed ID: 27369651
[No Abstract] [Full Text] [Related]
10. Idiopathic Non-histaminergic Angioedema: Successful Treatment with Omalizumab in Five Patients.
Faisant C; Du Thanh A; Mansard C; Deroux A; Boccon-Gibod I; Bouillet L
J Clin Immunol; 2017 Jan; 37(1):80-84. PubMed ID: 27826875
[TBL] [Abstract][Full Text] [Related]
11. Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting.
Palgan K; Bartuzi Z; Gotz-Zbikowska M
Int J Immunopathol Pharmacol; 2014; 27(1):109-12. PubMed ID: 24674685
[TBL] [Abstract][Full Text] [Related]
12. Persistent cow's milk anaphylaxis from early childhood monitored by IgE and BAT to cow's and human milk under therapy.
Schocker F; Recke A; Kull S; Worm M; Jappe U
Pediatr Allergy Immunol; 2018 Mar; 29(2):210-214. PubMed ID: 29197130
[No Abstract] [Full Text] [Related]
13. Unexpected Anaphylaxis After Completing a Desensitization Protocol to Oxaliplatin: Successful Adjuvant Use of Omalizumab.
Prieto-García A; Noguerado B; Rojas P; Torrado I; Rodríguez-Fernández A; Tornero P
J Investig Allergol Clin Immunol; 2019 Feb; 29(1):53-55. PubMed ID: 30785102
[No Abstract] [Full Text] [Related]
14. Efficacy of a single dose of omalizumab for the prevention of ethylene oxide intraoperative anaphylaxis.
Bilò MB; Corsi A; Brianzoni MF; Garritani MS; Antonicelli L
Ann Allergy Asthma Immunol; 2018 Aug; 121(2):249-250. PubMed ID: 29753833
[No Abstract] [Full Text] [Related]
15. The use of anti-IgE therapy beyond allergic asthma.
Stokes JR; Casale TB
J Allergy Clin Immunol Pract; 2015; 3(2):162-6. PubMed ID: 25609342
[TBL] [Abstract][Full Text] [Related]
16. Individually dosed omalizumab: an effective treatment for severe peanut allergy.
Brandström J; Vetander M; Lilja G; Johansson SG; Sundqvist AC; Kalm F; Nilsson C; Nopp A
Clin Exp Allergy; 2017 Apr; 47(4):540-550. PubMed ID: 27883239
[TBL] [Abstract][Full Text] [Related]
17. A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis.
Carter MC; Maric I; Brittain EH; Bai Y; Lumbard K; Bolan H; Cantave D; Scott LM; Metcalfe DD
J Allergy Clin Immunol; 2021 Mar; 147(3):1004-1010.e2. PubMed ID: 33220353
[TBL] [Abstract][Full Text] [Related]
18. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.
Navinés-Ferrer A; Serrano-Candelas E; Molina-Molina GJ; Martín M
J Immunol Res; 2016; 2016():8163803. PubMed ID: 28097159
[TBL] [Abstract][Full Text] [Related]
19. Food-dependent exercise-induced anaphylaxis with sensitization to tomato: Diagnostic approach involving food-exercise challenge.
Carrillo-Martin I; Chamorro-Pareja N; Haehn DA; Irizarry-Alvarado JM; Gonzalez-Estrada A
Ann Allergy Asthma Immunol; 2019 Sep; 123(3):316-318. PubMed ID: 31228627
[No Abstract] [Full Text] [Related]
20. Effects of omalizumab in patients with food allergy.
Rafi A; Do LT; Katz R; Sheinkopf LE; Simons CW; Klaustermeyer W
Allergy Asthma Proc; 2010; 31(1):76-83. PubMed ID: 20167148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
